335 related articles for article (PubMed ID: 16208307)
21. Role of renin-angiotensin system blockade in patients with diabetes mellitus.
Braga MF; Leiter LA
Am J Cardiol; 2009 Sep; 104(6):835-9. PubMed ID: 19733720
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular risk and cardiometabolic protection: role of glitazones.
Petrazzi L; Grassi D; Polidoro L; D'Aurelio A; Croce G; Properzi G; Tiberti S; Desideri G; Ferri C
J Nephrol; 2008; 21(6):826-35. PubMed ID: 19034866
[TBL] [Abstract][Full Text] [Related]
23. Prevention of type 2 diabetes.
Yale JF
Int J Clin Pract Suppl; 2000 Oct; (113):35-9. PubMed ID: 11965830
[TBL] [Abstract][Full Text] [Related]
24. [Postprandial blood glucose as the driving force in pathogenesis of type 2 diabetes].
Liebl A
Med Klin (Munich); 2003 Oct; 98 Suppl 1():7-11. PubMed ID: 14694835
[TBL] [Abstract][Full Text] [Related]
25. [The best of epidemiology and cardiovascular prevention in 2006].
Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP
Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566
[TBL] [Abstract][Full Text] [Related]
26. Can reducing peaks prevent type 2 diabetes: implication from recent diabetes prevention trials.
Haffner SM
Int J Clin Pract Suppl; 2002 Jul; (129):33-9. PubMed ID: 12166604
[TBL] [Abstract][Full Text] [Related]
27. Strategies for the prevention of type 2 diabetes.
Pfohl M; Schatz H
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S240-9. PubMed ID: 11460574
[TBL] [Abstract][Full Text] [Related]
28. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
[TBL] [Abstract][Full Text] [Related]
29. Early insulin treatment to prevent cardiovascular disease in prediabetes and overt diabetes.
Roman G; Hancu N
Horm Metab Res; 2009 Feb; 41(2):116-22. PubMed ID: 19214921
[TBL] [Abstract][Full Text] [Related]
30. Metformin for prevention of type 2 diabetes.
Hess AM; Sullivan DL
Ann Pharmacother; 2004; 38(7-8):1283-5. PubMed ID: 15150378
[TBL] [Abstract][Full Text] [Related]
31. Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications.
Krentz A
Diabetes Metab Res Rev; 2009 Feb; 25(2):112-26. PubMed ID: 19219860
[TBL] [Abstract][Full Text] [Related]
32. [Does targeted therapy of type 2 diabetes prevent cardiovascular incidents?].
Leschke M
Med Klin (Munich); 2003 Oct; 98 Suppl 1():12-6. PubMed ID: 14694836
[TBL] [Abstract][Full Text] [Related]
33. Strategies to prevent type 2 diabetes.
Abuissa H; Bel DS; O'keefe JH
Curr Med Res Opin; 2005 Jul; 21(7):1107-14. PubMed ID: 16004680
[TBL] [Abstract][Full Text] [Related]
34. Intensive therapy for diabetes through influence on innate immune system.
Li ZZ; Liu JB; Li L; Jiao L; Chen L
Med Hypotheses; 2009 Jun; 72(6):675-6. PubMed ID: 19264419
[TBL] [Abstract][Full Text] [Related]
35. [Prevention of type 2 diabetes--an overview].
Qvigstad E
Tidsskr Nor Laegeforen; 2004 Dec; 124(23):3047-50. PubMed ID: 15586184
[TBL] [Abstract][Full Text] [Related]
36. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
Flórez H
Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
[TBL] [Abstract][Full Text] [Related]
37. Prevention of type 2 diabetes in the prediabetic population.
Maji D; Roy RU; Das S
J Indian Med Assoc; 2005 Nov; 103(11):609-11. PubMed ID: 16570766
[TBL] [Abstract][Full Text] [Related]
38. Clinical and cost-effectiveness of primary prevention of Type 2 diabetes in a 'real world' routine healthcare setting: model based on the KORA Survey 2000.
Icks A; Rathmann W; Haastert B; Gandjour A; Holle R; John J; Giani G;
Diabet Med; 2007 May; 24(5):473-80. PubMed ID: 17381502
[TBL] [Abstract][Full Text] [Related]
39. Protection of pancreatic beta-cells: is it feasible?
Bonora E
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular drugs as antidiabetic agents: evidence for the prevention of type 2 diabetes.
Macfarlane DP; Paterson KR; Fisher M
Diabetes Obes Metab; 2008 Jul; 10(7):533-44. PubMed ID: 18248492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]